Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Two-arm, Open, 24-week Study to Evaluate the Effect of a Smart Phone-based Patient Support Tool on Duration of Treatment in Patients Prescribed Rosuvastatin in China

NCT02433288 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02433288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02433288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Two-arm, Open, 24-week Study to Evaluate the Effect of a Smart Phone-based Patient Support Tool on Duration of Treatment in Patients Prescribed Rosuvastatin in China
Lead sponsor
AstraZeneca
Phase
Not applicable
Overall status
Completed
Start date
July 20, 2015
Completion date
October 28, 2016
Enrollment
885 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia, hyperlipidemia